Life Insurance in India, Key Trends and Opportunities to 2015

Published: November 2011
No. of Pages: 242
Price: $ 1950


Synopsis
The report provides top-level market analysis, information and insights of the Indian life insurance industry, including:
• The Indian life insurance industry’s growth prospects by product category and customer segment
• The various distribution channels in the Indian life insurance industry
• The competitive landscape in the life insurance industry
• A description of the life reinsurance market in India

Executive Summary
India’s insurance sector is expected to grow even faster than the country’s overall economic growth, opening up new business avenues across the industry. With a large number of insurance providers already operating in the country, the Indian insurance industry has shown early signs of entering a consolidation phase, and an improved distribution infrastructure, the adoption of new channels and differentiated product offerings will continue to change the competitive landscape significantly.
India’s low life insurance penetration rate and the rising awareness of the need for insurance will be key growth factors in the Indian insurance industry. Favorable foreign investment policies and increased capital-raising options will also create an environment for collaborations and joint ventures. India’s reinsurance market is also expected to continue growing, driven mainly by growth in non-life and accident and health insurance."

Scope
This report provides a comprehensive analysis of the life insurance market in India:
• It provides historical values for India’s life insurance industry for the report’s 2006–2010 review period and forecast figures for the 2011–2015 forecast period
• It offers a detailed analysis of the key sub-segments in India’s life insurance industry, along with market forecasts until 2015
• It covers an exhaustive list of parameters, including written premium, incurred loss, loss ratio, commissions and expenses, combined ratio, frauds and crimes, total assets, total investment income and retentions
• It analyses the various distribution channels for life insurance products in India
• Using Porter’s industry-standard “Five Forces” analysis, it details the competitive landscape in India for the life insurance business
• It provides a detailed analysis of the reinsurance market in India and its growth prospects
• It profiles the top life insurance companies in India, and outlines the key regulations affecting them

Reasons To Buy
• Make strategic business decisions using top-level historic and forecast market data related to the Indian life insurance industry and each sector within it
• Understand the demand-side dynamics, key market trends and growth opportunities within the Indian life insurance industry
• Assess the competitive dynamics in the life insurance industry, along with the reinsurance segment
• Identify the growth opportunities and industry dynamics within seven key product categories
• Gain insights into key regulations governing the Indian insurance industry and its impact on companies and the industry's future

Key Highlights
• The significant growth in the Indian life insurance market in the review period can be attributed to key growth drivers such as population growth, robust economic growth, lucrative tax benefits, the rising disposable income of India’s middle-class population, and increased awareness of the need for insurance, especially among younger people
• India is the world’s twelfth-largest life insurance market, and the fourth-largest in the Asia-Pacific region
• By 2015, it is expected to surpass South Korea to emerge as the third-largest life insurance Asia-Pacific market after China and Japan
• In 2010, the individual life insurance segment accounted for 74.8% of the total Indian life insurance industry, whereas the group life insurance market had a considerably lower market share of 25.2%
• Indian customers are increasingly demanding insurance products that offer assured income through annuities
• Distribution channels such as bancassurance have gained significant market share in the review period

European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive)

Published: November 2011
Price: $ 11495

In 2010, the European diagnostic and interventional ophthalmic device market was valued at over €650 million. The rate of market growth will accelerate due to increases in ocular conditions such as cataracts. The European ophthalmic devices market includes diagnostic devices that are used for identifying ocular conditions, such as cataracts, glaucoma retinal detachments, and refractive problems. The interventional device market included intraocular lenses (IOLs), which are implantable lenses used for replacing the natural lens when it has been damaged by cataracts.

The market segments covered in this report include: 

• Optical Coherence Tomographers

• Fundus Cameras

• Slit Lamps

• Perimeters

• Tonometers

• Ophthalmic Ultrasound Equipment

• Wavefront Aberrometers

• Corneal Topographers

• Intraocular Lenses

• Phacoemulsification Consoles

• Ophthalmic Viscosurgical Devices

The countries covered in this report include:

• Austria

• Benelux

• France

• Germany

• Italy

• Portugal

• Scandinavia

• Spain

• Switzerland

• The United Kingdom

Within the European Ophthalmic device market, companies such as Alcon, AMO, Bausch & Lomb, Carl Zeiss, Haag-Streit, Meditec and Oculus lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

China Permanent Magnet Switch Industry Report, 2011

Published: November 2011
No. of Pages: 58
Price: $ 1500


Permanent magnet switches refer to electric switches with permanent magnetic actuators. Compared with conventional spring actuator switches, they hold a lot of advantages, say, less components, smaller size, longer life and higher performance, and serve as substitutes for spring switches.

China permanent magnet switch industry is still at the primary stage of development. In 2010, China produced only 35,000 sets of permanent magnet switches. As their performance has been improved gradually and promotion has been enhanced, permanent magnet switches will be applied more widely in large-scale industrial enterprises in steel, petrochemical, coal, etc. It is estimated that the market scale of permanent magnet switches will increase to 65,000 sets in China in 2015 with the average growth rate of 13.18%.

Browse All: Industry Profiles Market

At present, large permanent magnet switch manufacturers can be mainly divided into foreign-funded and China-funded enterprises in China.

Tavrida Electric and ABB are representatives in the first category. Tavrida’s products mainly serve China railway system, while ABB focuses on smart grid. Besides, Schneider Electric and Eton have also launched small batches of products into the Chinese market.

Yongda Group is a prominent China-funded enterprise, occupying 21.92% of the Chinese permanent magnet switch market in 2010. Till Oct. 2011, Yongda Group has achieved mass production of 12kV and 40.5kV permanent magnet switches, and successfully developed 24kV and 31.5kV permanent magnet switches but still without mass production. Chinese enterprises which can massively produce permanent magnet switches also include CREAT, Dongyuan Electrical, Xinlong Electrical, Senyuan Electric, etc.

China Permanent Magnet Switch Industry Forecast Report, 2011” of ResearchInChina mainly covers the following contents:
• Policies for and features of China permanent magnet switch industry;
• 2012-2015 forecast of China permanent magnet switch industry, including the forecast of output, output value and profit;
• Development of foreign-funded permanent magnet switch enterprises in China, including the overall development, expansion in China, and market promotion of permanent magnet switch products in China;
• Development of China-funded permanent magnet switch enterprises, including the overall operation, permanent magnet switch product R&D, production, capacity, output, development plan, etc.

Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems

Published: November 2011
No. of Pages: 150
Price: $ 3500


Radiography includes mammography, computed tomography, traditional x-ray and digital x-ray. These imaging procedures are affected by a number of factors: advances in technology, consumer expectations for healthcare, declining reimbursement and coverage of medical expenses by insurances companies and the aging of the population are among the factors driving these imaging markets.

This report, Medical Imaging Market from Kalorama Information, details these these factors and provides 2011 market size and forecast to 2015 for the following markets
• Digital X-Ray
• Traditional X-Ray
• Dental X-Ray
• Film
• CT
• Mammography
• Fluoroscopy
• Regional Markets (US, Europe, Asia, ROW) for these segments
Digital systems replace the conventional film cassette with an electronic receptor that directly converts the x-rays to digital images. Over the years, Kalorama Information analyst Joe Constance has tracked this trend of digital radiography. Digital technology enables x-ray modalities to detect problem sites more rapidly and with greater accuracy. These capabilities are helping fuel hospitals' transition from film-based systems to filmless environments. At the same time there are practical limiters to digital and areas where film-based systems will still be useful, and the report details these.

This report analyzes the current and potential world market for medical and dental x-ray systems. Various modalities that use x-rays to create images, such as fluoroscopy and CT, are included in the report. Also reviewed is the market for medical and dental x-ray film. This report emphasizes the current and future markets for these products. This report generally reviews the nature and direction of research, as well as future markets. It also profiles several companies involved in marketing medical and dental x-ray equipment, and medical and dental x-ray film, including:
• Adimec
• AFP Imaging Corp.
• Canon Inc.
• Carestream Health Inc.
• C.M.C. Biotech Co. Ltd.
• dpiX LLC
• Fischer Industries Inc.
• Tower Semiconductor Ltd.
• Trixell
• United Radiology Systems Inc.
• Varian Medical Systems
Market forecasts are based on an examination of current market conditions and on investigations into the development of new products by key companies. The market data provide multiple year forecasts for all product segments covered in the report. The information presented in this report has been generated by data gathered from company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. In addition, interviews were conducted with company executives.

Browse All: Medical Devices Market

Dramatic Change in X-Ray Market as Digital Systems Exceed Traditional
Kalorama Information estimates that digital x-ray system sales will exceed those of traditional x-ray systems used for a medical (non-dental) purpose in 2011. According to the healthcare market research publisher, revenues for digital x-ray systems are the largest component of the $12 billion radiography market, slightly higher than the firm's projection for traditional systems. Kalorama notes in its new report: Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems, that digital x-ray will exhibit the highest growth in the radiography market which includes mammography, fluoroscopy, dental imaging, computed tomography, and analog x-ray systems.

The report states that it is initially expensive to purchase a digital x-ray system such as the Philips DigitalDiagnost, the Siemens AXIOM Multix, or products from several other companies. But with continued use, operating costs are lower than with standard radiography. Digital systems don't require film and processing, the annual cost of which can be as great as the capital cost of standard radiographic equipment. And, once a digital system is installed, large film storage facilities are no longer needed.

"The initial cost of buying a digital system is several times higher than a conventional system," said Joe Constance, the report's author and imaging analyst for Kalorama Information. "But the high cost can be justified, particularly in a high volume setting."

Kalorama finds that it is not the cost savings but convenience and usability that are especially driving system sales. Diagnosticians can retrieve digital x-rays almost instantly from a computer terminal. The movement to digitize diagnostic imaging is closely tied to the movement to boost health care efficiency through the digitization of health care records - electronic medical records (EMRs). As a result of steadily increasing digital business, radiology equipment manufacturers that once had significant involvement in film and film-related technologies have been investing in alternative digital technologies.

The report also notes changes in the competitors operating in x-ray equipment. Because innovation relies greatly on funding, large companies with flexible budgets for research and development have owned a sizable percentage of the market. But others, such as Kodak, have left the business. That company decided to focus its attention on the significant digital growth opportunities in consumer and professional imaging and graphic communications.

The report contains analysis of the market including company profiles, regional market breakouts, key trends and market shares of competitors.

China Healthcare Reform and Its Impact on IVD, Medical Device and Pharmaceutical Markets

Published: October2011
No. of Pages: 167
Price: $ 3500


China’s rapid economic development and numerous steps of reform undertaken by the Chinese central government since 1997 had clear and observable effects upon China’s total healthcare services market and product markets for pharmaceuticals, medical devices, and in vitro diagnostics (IVD). This progress has been augmented by a Reform program in 2009, including increased funding, to improve services.

What are the workings of China's healthcare system? How much progress has been made towards the promised vision of the CPCC in 2008 to provide "convenient and affordable access" to its people? What are the effects on foreign companies seeking to benefit from an increase in healthcare-related funding? Where are the best opportunities in China for marketers. Analyst Emil Salazar focuses on these questions.

The report China Healthcare Reform Impact contains a comprehensive overview of the Chinese healthcare system with important data for marketers to China. It discusses healthcare reform plans and where funds were spent. It also describes the role foreign companies play. As part of its analysis, the report includes the following information:
• Statistics on Chinese Hospitals, Community Health Centers and Clinics
• Top and Bottom City Markets for Urban Healthcare
• Top and Bottom Rural Regions
• Challenges for Foreign-Owned MNCs in China
• Government Healthcare Spending
• Foreign-Invested Manufacturing Enterprises in China
• Share of Government Funded Healthcare vs. Out of Pocket
• Domestic Healthcare Industries
• Population and Age Statistics
• Incidence Rates for Infectious Diseases
• Cancer Rates in China
• Regulation of Drugs and Devices in China
• U.S. Product Exports to China
• Key Analyst Conclusions

In addition to providing useful background information and a thorough analysis of China's healthcare changes, the report China Healthcare Reform and Its Impact on IVD, Medical Device and Pharmaceutical Markets provides data for business planning. The report also takes a look at the status and forecast of the three key healthcare markets in China:
• The Chinese Market for IVD products
• Regional Breakout of Chinese IVD Market (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)
• The Chinese Market for Medical Device Products
• Regional Breakout of Chinese Medical Device Market (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)
• Segment Breakout of Chinese Medical Device Market(Surgical Instrument, Disposable, Patient Monitoring, IVD, Imaging, Orthopedic, Other)
• The Chinese Market for Pharmaceutical Products
• Regional Breakout of Pharmaceutical Market(Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)
• Segment Breakout of Pharmaceutical Market (Cardiovascular, Gastrointestinal, Anti-Infectives, Neurotherapeutics, Oncology, Respiratory, Other)
This essential resource for anyone marketing a healthcare product to China was constructed using a combination of primary and secondary sources. Corporate reports, trade publications government information and medical journals, previous market research studies conducted by Kalorama and other sources were used. In some cases, interviews were used to determine forecasts and key trends.

All Kalorama reports advertise the single user price, which limits access to one user. We also feature department and global pricing for reports that will be utilized by more than one user at your company. Please ask your sales representative or select the correct license on our website.

U.S. Market for Dental Prosthetics and CAD/CAM Devices 2011

Published: October 2011
No. of Pages: 275
Price: $ 7495


In 2010, the U.S. market for dental prosthetics, which includes crowns, bridges, inlays/onlays, veneers and dentures, exceeded $11 billion. The market has recovered from the slowdown caused by the economic recession of 2008 and 2009. Lingering effects of the recession continued to affect various segments of the market adversely; however, the prosthetics market is expected to continue to grow as the number of patients requiring dental prosthetics increases.

Browse All: Medical Devices Market Research 


The market segments covered in this report U.S. Market for Dental Prosthetics and CAD/CAM Devices 2011 include:
• Crowns and Bridges
• Inlays and onlays
• Veneers
• Dentures
• CAD/CAM Systems
• CAD/CAM Blocks and Prosthetic Devices
• Intra-Oral Digital Impression-Taking Systems
• Automated Prosthetics Manufacturing
• Rapid Prototyping Systems/3D Printing

Within the dental prosthetics market, companies such as Dental Services Group, Glidewell Laboratories and National Dentex Corporation lead the market. Within the CAD/CAM System market companies such as 3M, DENSPLY and Sirona lead the market. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

Cell Culture: The World Market for Media, Sera and Reagents, 3rd. Edition

Published: October 2011

No. of Pages: 155

Price: $ 3500

Several cell culture-derived biopharmaceutical drugs were launched in the US and European markets in 2010. Biopharmaceuticals (recombinant proteins, monoclonal antibody and nucleic acid-based products) represent the fastest growing sector in the pharmaceutical industry. Driving the extraordinary interest in biopharmaceuticals is the ability of these large proteins to target diseases in a very specific manner, thus maximizing efficacy while minimizing side effects.

Growth in the development and production of biopharmaceuticals is the most significant driver of the cell culture market. Biological products are developed from large and complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques. Protein-based biopharmaceuticals are invariably produced by an initial cell culture step (upstream processing), followed by product recovery, purification and formulation into final product format (downstream processing).

This report analyzes the world market for the cell cultures used in these steps and the major trends driving this market. Forecasts and current market sizing are provided in three specific segments:

• Media,

• Sera, and

• Reagents

Browse All: Biotechnology Market Research Reports

In addition to a thorough discussion of the technologies and techniques currently employed and emerging in the cell culture area, the Kalorama's exhaustive report provides specific information on:

• Market Size, growth, and forecasts of the segments through 2015

• Competitive Market Share by leading supplier as of 2010.

• Estimated Market Share by Region (North America, Europe, U.S.)

• Key Market Drivers and Restraints for suppliers, including discussions of biopharmaceutical pipelines, biomedical R&D directions, and the future of transgenic plant and animal production.

• Review of the various expression systems (Bacteria, Yeast, Insect, and Mammal) and the biopharmaceutical product manufactured by these systems

• Discussion of the preferences in media types vying for dominance in the market, including the following:

ADCF - animal derived component free media

CD - chemically defined media

CSFM - complete serum free medium

PF - protein free media

SF - serum free media

SFM - serum free medium

• Major Trends Impacting the Market stem cell research (including plans of major companies)cell culture-based vaccine Production and generic bipharmaceuticals

• Profiles of Leading Suppliers and information about M&A activities in recent years

The information for this report Cell Culture: The World Market for Media, Sera and Reagents, 3rd. Edition was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with key industry officials, consultants, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company and cell culture supply company representatives included marketing directors, division managers, and product representatives.

All Kalorama reports advertise the single user price, which limits access to one user. We also feature department and global pricing for reports that will be utilized by more than one user at your company. Please ask your sales representative or select the correct license on our website.